Bolsa ES - Gráfico Interactivo de Análisis Técnico de Sepracor Inc. [SEPR]

Busque más análisis técnicos aquí en nuestro foro: Análisis Técnicos

Nota: Los datos después de 2009-10-29 son temporales y pueden tener un valor de Apertura incorrecto hasta nueva actualización...
Cambiar para Gráfico Estático de Sepracor Inc.

Sepracor Inc. - [Ticker: SEPR]
Última Transacción		Hora de Cotización	N/A - N/A
Variación	()	Rango 52 Semanas	[0,000 - 0,000]
Máximo		Mínimo
Volumen		Volumen Medio (3m)	0
Demanda / Oferta	N/A	Yield	N/A
Cierre Anterior	0,000	PER	12,69%
Apertura		EPS	0,00
Fecha Ex-Dividendo	N/A	Fecha Dividendo	N/A
Capitalización Bursátil	3	Objetivo Estimado 1 Año	N/A
Nota: Los datos pueden tener un retraso de algunos minutos.

Noticias de Sepracor Inc. [SEPR]: (ordenadas por relevancia)

Harvard Business Review: Mandating English is a must for global companies
Boston.com
In 2008, the Japanese drug maker Takeda Pharmaceutical Co. bought Millennium Pharmaceuticals Inc. of Cambridge. A year later, another Japanese company, Dainippon Sumitomo Pharma Co., disclosed plans to acquire Sepracor Inc., a Marlborough drug company ...

y más »

You Docs: Reduce cancer risk by eating whole grains, veggies
Houston Chronicle
(Richard Carson/special to the Chronicle) Photo: RICHARD CARSON / HC ALVESCO(R) (Ciclesonide) Inhalation Aerosol Now Available in US for Treatment of Asthma (Graphic: Business Wire) Photo: SteveLesnick 212-736-6009 / Sepracor Inc. A doctor can aid in ...

Photo Release -- XOMA Integrates Research, Preclinical and Clinical ...
MarketWatch (press release)
From 1996 to 2002, Dr. Rubin served as Senior Vice President, Development, and later as Executive Vice President, Research & Development at Sepracor. He was responsible for the successful development of all of Sepracor's internally developed approved ...

y más »

CME Outfitters Demonstrates Best in Class at the 37th Annual Alliance for ...
DigitalJournal.com (press release)
USF Health and CME Outfitters also acknowledges support from AstraZeneca, Cephalon, Inc., Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC, Lilly USA, LLC, Pfizer, Inc. and Sepracor, Inc. for the ?Outcomes from the 3rd ...

y más »

VECTURA GROUP PLC : Board appointment
4-traders
Between 1986 and 2002, Trevor held a number of management positions including at Sepracor, Accenture and GlaxoWellcome. Trevor trained as a microbiologist at University of Reading, obtaining a PhD in microbial biochemistry from the University of Wales ...

Biotech Past, Biotech Present: Reflections on the IPO Window of 1991-1994
Forbes
Nearly a hundred biotech companies went public from 1991-1994, including a number of the great companies that have become household biotech names: Alkermes, Amylin, Cephalon, Gilead, Human Genome Sciences, Imclone, Isis, MedImmune, PDL, Sepracor, ...

Dr. Rubin Promoted to the Newly Created Position of Senior Vice President ...
PharmaLive (press release) (subscription)
From 1996 to 2002, Dr. Rubin served as Senior Vice President, Development, and later as Executive Vice President, Research & Development at Sepracor. He was responsible for the successful development of all of Sepracor's internally developed approved ...

Vectura's Chief Operations Officer appointed to the Board
PharmaLive (press release) (subscription)
Between 1986 and 2002, Trevor held a number of management positions including at Sepracor, Accenture and GlaxoWellcome. Trevor trained as a microbiologist at University of Reading, obtaining a PhD in microbial biochemistry from the University of Wales ...

y más »

Para más noticias de Sepracor Inc. hacer clic aquí:
Noticias de Sepracor Inc.